The number of people with susceptibility test result for rifampicin in Oman
Oman: The number of people with susceptibility test result for rifampicin was 144 in 2021. ▼ Falling
Latest (2021)
144
Change on year
down 33.9%
World rank
102nd
of 155 countries
All-time high
299
in 2019
All-time low
144
in 2021
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Oman, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
Oman recorded 144 for the number of people with susceptibility test result for rifampicin in 2021. That is the lowest value across all 5 years on record.
The figure is down 33.9% on the previous year and down 23.8% over five years.
That places Oman 102nd out of 155 countries with data for 2021, putting it in the middle of the range.
The number of people with susceptibility test result for rifampicin in Oman, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 189 | — |
| 2018 | 174 | -7.9% |
| 2019 | 299 | +71.8% |
| 2020 | 218 | -27.1% |
| 2021 | 144 | -33.9% |
Oman compared with similar countries
- Oman's 144 is above the median for high income countries, which is 142, 1.0× the median. (61 countries reporting)
- Oman's 144 is below the median for Middle East, North Africa, Afghanistan & Pakistan, which is 406, 35% of the median. (16 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 220.67 | 174 | 299 | 3 |
| 2020s | 181 | 144 | 218 | 2 |
Countries ranked near Oman
More health data for Oman
- Un projection of annual infant deaths, annual growth rate -0.8969 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.3507 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 429.2 deaths per 1,000 people (2090)
- Number of infants who die before age 1 221 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 1.89 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0388 units per person (2025)
- Population ages 00-04, male, annual growth rate 2.06 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Oman?
- The number of people with susceptibility test result for rifampicin in Oman was 144 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Oman?
- The highest recorded value was 299 in 2019.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Oman?
- The lowest recorded value was 144 in 2021.
- How does Oman rank for the number of people with susceptibility test result for rifampicin?
- Oman ranks 102nd out of 155 countries with data for 2021.
- Where does this Oman data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).